Recently it has been shown that postoperative analgesia can be produced and maintained by the inhalation of nebulized morphine [1] . However, the use of this technique in a larger number of patients revealed that pain relief was not always satisfactory. The aim of this study therefore was to evaluate the bioavailability of morphine administered by inhalation.
SUMMARY

During anaesthesia seven patients received a bolus of morphine 10 mg injected into the nebulization reservoir placed between the tracheal tube and the anaesthetic circle (IH)
allow almost complete elimination of the morphine given by nebulization (IH). Upon complaint of pain on the 5th day after operation, morphine 10 mg was administered i.m. into the gluteus maximus (IM). Venous blood samples were taken before and every 15 min for 4.5 h after the two morphine administrations for measurement of free morphine immunoreactivity by radioimmunoassay (Diagnostic Products Corporation, Los Angeles, cross reactivity to morphine-3-glucuronide 0.22%).
Pharmacokinetic data were calculated for each subject. Maximum serum concentration of morphine (C 11 ™) and the time of its occurrence (T""" three) plotted on a logarithmic axis declined linearly. The area under the curves (AUC) was calculated by the linear trapezoidal method and was extrapolated to infinity by integrating the terminal elimination phase. Individual relative bioavailabilities of the inhaled morphine (F) were calculated by dividing the area under the curve after morphine inhalation (IH) by that after i.m. (IM) administration for each subject.
For statistical analysis, the non-parametric Wilcoxon matched pairs signed rank test was used.
There was marked interindividual variation in the serum morphine concentrations when morphine was given by either inhalation or i.m. injection. In most of the patients receiving nebulized morphine the maximum serum concentration was reached within 45 min, when the mean peak concentration was 10.7 (SEM 1.6) ng ml" 1 ; the maximum serum concentration independent of time was 11.8 (SEM 1.9) ng ml" 1 ( fig.  lA, table I ). In contrast, following i.m. administration of morphine a mean serum morphine concentration of 63.5 (SEM 6.2) ng ml" 1 was reached within 15 min; the maximum serum concentration independent of time was 70.6 (SEM 6.4) (fig. 1B, table I ). The maximum serum morphine concentration (C 1 "*) after inhalation was approximately six times lower than that after i.m. administration and the times of their occurrence differed significantly (P < 0.001).
The relative bioavailability of morphine following inhalation was approximately 9-35%, with a mean of approximately 17%.
COMMENT
Gaensler and colleagues [2] observed that only 7-30 % of a nebulized drug inhaled into the lungs was absorbed into the circulation, as at least 50 % of the drug is lost on expiration. In addition, loss of drug results from absorption onto equipment and some morphine may be taken up by endothelial cells [3] . Furthermore, patients may swallow drug present in the pharynx.
Our results of the bioavailability of inhaled nebulized morphine support previous observations in which a five-fold difference in serum morphine concentration was found following the inhalation and i.v. administration of morphine given to achieve similar levels of postoperative analgesia [l] . Plateau morphine concentrations of approximately 4 ng ml" 1 and 20 ng ml" 1 were achieved within 1 h after commencing inhalation or i.v. treatment, respectively [1] . It is tempting to speculate, therefore, that the mode of analgesia after inhalation of morphine differs from that achieved following other parenteral routes of administration.
The low serum morphine concentrations observed after inhalation of nebulized morphine were found to be associated with fewer sideeffects than those seen after i.v. administration. Moreover, it has been found recently that the inhalation of morphine does not increase resting airway resistance [4] , which was thought previously to be a severe side-effect of this method.
The great interindividual differences in systemic absorption and the fact that lower serum concentrations of morphine occur after inhalation than following oral [5] or rectal [6] administration suggest that consistent pain relief cannot be anticipated with nebulized morphine and that repeated administration may result in potential hazard.
